Article
Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.
Molecular and cellular biology - 1 Nov 2004
Gangloff Yann-Gaël, Mueller Matthias, Dann Stephen G, Svoboda Petr, Sticker Melanie, Spetz Jean-Francois, Um Sung Hee, Brown Eric J, Cereghini Silvia, Thomas George, Kozma Sara C
Abstract excerpt
The mammalian target of rapamycin (mTOR) is a key component of a signaling pathway which integrates inputs from nutrients and growth factors to regulate cell growth. Recent studies demonstrated that mice harboring an ethylnitrosourea-induced mutation in the gene encoding mTOR die at embryonic day 12.5 (E12.5). However, others have shown that the treatment of E4.5 blastocysts with rapamycin blocks trophoblast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
